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According to Neer et al. (1983), cuff-tear arthropathy (CTA) 
is described as a large rotator cuff tear followed by inactivity, 
disuse of the shoulder, leaking of synovial fluid, and insta-
bility of the humeral head. Radiographic characteristics are 
superior migration, collapse of the proximal aspect of the 
humeral articular surface, and erosion or acetabularization of 
the acromion (Neer et al. 1983, Feeley et al. 2009). The clini-
cal symptoms are pain, arthritis, muscle atrophy, decreased 
range of motion, and in a subset of late-stage patients a pseu-
doparalytic shoulder (Neer et al. 1983, Ramirez et al. 2012, 
Smith et al. 2012). In these cases, the result of reverse shoul-
der arthroplasty (RSA) is better than that of resurfacing hemi-
arthroplasty (RHA) (Young et al. 2013). There are, however, 
concerns not only regarding the longevity of RSA but also the 
outcome of an eventual revision procedure. Thus, RHA with 
posterior and superior extended articular surface has been sug-
gested as an option in the treatment of younger patients with 
long life expectancy. 
We compared patient-reported outcome and revision rates 
of RHA and RSA in the treatment of CTA in average patients 
and in patients younger than 65 years.
Patients and methods
Data were obtained from the Danish Shoulder Arthroplasty 
Registry (DSR). All Danish public hospitals and private clinics 
report to this registry. More than 90% of the procedures have 
been captured each year since 2007 when compared with the 
national patient registry (DSR 2016). Surgeons report infor-
mation concerning the patient (name, date of birth, and sex) 
and the procedure (hospital, date of surgery, diagnosis, previ-
ous surgery, and arthroplasty type) electronically at the time of 
Background and purpose — Reverse shoulder arthro-
plasty (RSA) has become the treatment of choice for cuff-
tear arthropathy. There are, however, concerns about the lon-
gevity and the outcome of an eventual revision procedure. 
Thus, resurfacing hemiarthroplasty (RHA) with extended 
articular surface has been suggested for younger patients. We 
compared the patient-reported outcome of these arthroplasty 
designs for cuff-tear arthropathy.
Patients and methods — We included patients oper-
ated on because of cuff-tear arthropathy and reported to the 
Danish Shoulder Arthroplasty Registry (DSR) from Janu-
ary 1, 2006 to December 31, 2013. 117 RHA cases were 
matched by age and sex with 233 RSA controls. 34 of the 
RHAs were conventional and 67 were RHAs with extended 
articular surface. The Western Ontario Osteoarthritis of the 
Shoulder (WOOS) Index at 1 year was used as primary out-
come. The score was converted to a percentage of a maxi-
mum score. Revision, defined as removal or exchange of any 
component or the addition of a glenoid component, was used 
as secondary outcome.
Results — Median WOOS was 49 (30–81) for RHA and 
77 (50–92) for RSA (p < 0.001). For patients younger than 
65 years, median WOOS was 58 (44–80) after RHA, similar 
to the 54 after RSA (37–85). For patients older than 65 years, 
median WOOS was 48 (28–82) after RHA and 79 (55–92) 
after RSA (p < 0.001).
Interpretation — In all patients RSA had a clinically 
and statistically better patient-reported outcome than RHA. 
However, in patients younger than 65 years the functional 
outcome was similar and poor for either arthroplasty type. 
The optimal treatment of CTA in young patients remains a 
challenge.
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tionnaires (e.g., the Oxford Shoulder Score [OSS)]) (Rasmus-
sen et al. 2013). We defined a clinical failure as a WOOS below 
50. Revision is defined as removal or exchange of any compo-
nent or the addition of a glenoid component. 
All primary shoulder arthroplasties for CTA reported to the 
registry from January 1, 2006 to December 31, 2013 were 
identified (n = 891). We matched each RHA (n = 119) with 2 
RSA controls based on age, sex, and response of the WOOS 
at 1 year. For patients younger than 60 years we accepted 
matches in intervals of 5 years. 2 patients did not have match-
ing controls available (they were both men and 43 years old). 
1 had a WOOS of 73 and 1 was recorded as a non-responder 
regarding WOOS. A 49-year-old man with a WOOS of 47 was 
matched with only 1 control. Thus, 117 RHAs and 233 RSAs 
were included in the study. 73% had a complete WOOS, 24% 
did not respond to WOOS, and 3% were revised or died within 
the first year after surgery. 
Statistics
Data on WOOS were not normally distributed. Thus, the 
results are presented as median and interquartile range (IQR) 
and the Mann–Whitney U-test was used when groups were 
compared. P-value < 0.05 was considered significant. The 
analysis was performed using IBM SPSS statistics version 
24.0 (IBM Corp, Armonk, NY, USA)
Ethics, funding, and potential conflicts of interest
Ethics approval was from the Danish Patient Safety Depart-
ment (Study number 3-3013-1862/1/ Reference MOAD from 
March 28, 2017). No funding was recieved. No conflicts of 
interest.
Results
The mean age of all patients was 73 years (50–92) and 60% 
were women. The median WOOS for all patients was 49 (30–
81) for RHA and 77 (50–92) for RSA, (p < 0.001). There were 
44 (52%) RHAs and 42 (25%) RSAs with a WOOS below 
50 (Figure). 7 (6%) RHAs and 13 (6%) RSAs were revised. 
The reasons for revision after RHA were glenoid attrition (n 
= 2), infection (n = 1), luxation (n = 1), other (n = 1), or no 
reason reported (n = 2). The reasons for revision after RSA 
were infection (n = 5), luxation (n = 3), loosening (n = 3), 
other (n = 1), or no reason reported (n = 1). 
Of the 117 RHAs, 34 were conventional RHAs and 67 had 
posterior and superior extended articular surface. Informa-
tion regarding the subtype was missing in 16 cases. In the 
group with posterior and superior extended articular surface 
35 (52%) patients were women, mean age was 73 years, and 
the response rate of WOOS was 73%. In the group with con-
ventional RHAs 22 (65%) patients were women, mean age 
was 73 years, and the response rate of WOOS was 71%. The 
median WOOS was 48 (33–80) for RHA with posterior and 
superior extended articular surface and 57 (38–92) for con-
ventional RHA (p = 0.4). 5 (8%) RHAs with posterior and 
superior extended articular surface and 1 (3%) conventional 
RHA were revised. 
For patients younger than 65 years the median WOOS was 
similar for RHA (n = 19) and RSA (n = 32) at 58 (44–80) 
and 54 (37–85). For patients older than 65 years the median 
WOOS for RHA (n = 66) and RSA (n = 137) was 48 (28–82) 
and 79 (55–92) (p < 0.001).
Discussion
We found the patient-reported outcome after RSA to be better 
than after RHA. For patients younger than 65 years the results 
were disappointing for both arthroplasty types. The revision 
rates were the same. 52% of RHAs and 25% of RSAs had a 
WOOS below 50 but only 6% were revised for both arthro-
plasty designs. A reason for this difference might be restraint 
in revision arthroplasties because of poor outcome. 
WOOS distribution after resurfacing arthroplasties (left panel) and reverse arthroplas-
ties (right panel).
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the operation. 10–14 months after the procedure, 
the patient-reported outcome is collected using 
the Western Ontario Osteoarthritis of the Shoul-
der (WOOS) questionnaire index. WOOS consists 
of 19 questions focused on shoulder-related qual-
ity of life. Each question is answered on a scale 
from 0 to 100; thus the total score ranges from 0 to 
1,900. In this study, the raw WOOS score was con-
verted to a percentage of a maximum score where 
a score of 100 was regarded as a healthy shoulder 
with no functional impairment (Lo et al. 2001). A 
validated Danish version of WOOS is used in the 
DSR (Rasmussen et al. 2013). To our knowledge, 
a minimal clinically important difference WOOS 
has not been established and validated. We used 
a value of 10% of a maximum score, which is an 
extrapolation from other shoulder-specific ques-
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The results of RHA or RSA for CTA have frequently been 
reported in small case series, but to our knowledge there are 
only 2 studies comparing hemiarthroplasty with RSA for CTA. 
From the New Zealand Joint Registry Young et al. (2013) 
compared 102 hemiarthroplasties with 102 RSAs. 77 of 102 
hemiarthroplasties were RHAs with posterior and superior 
extended articular surface. The patients were matched for age, 
sex, and ASA scores, and the functional outcome was evalu-
ated using the OSS at 6 months and 5 years postoperatively 
(Young et al. 2013). They found no differences in mortal-
ity, revision rates, or OSS for patients younger than 65 years 
when comparing 24 hemiarthroplasties and 20 RSA. As in our 
study there was a statistically significant difference in func-
tional outcome overall and in patients older than 65 years. The 
authors did not report separate results of the 77 RHAs with 
posterior and superior extended articular surface (Young et al. 
2013). A retrospective study by Leung et al. (2012) from a 
10-year period compared 20 hemiarthroplasties and 36 RSAs 
for CTA at minimum 2 years’ follow-up. They found a better 
Shoulder Pain and Disability Index (SPADI) for RSA. They 
found high complication rates in 14 patients from both arthro-
plasty types, with infections and pain in the hemiarthroplasty 
group and infection, loosening, and fracture of acromion or 
humerus in the RSA group (Leung et al. 2012). 
A radiographic study by Leung et al. (2017) with 97 arthro-
plasties reported 26 radiographic complications, e.g., acro-
mion remodeling, fracture, subluxation, or loosening after 
RHA with posterior and superior extended articular surface 
for CTA. Most of these complications were seen within the 
first 3 months postoperatively. Occurrence of postoperative 
radiographic complications was associated with revision. 8 
arthroplasties were revised (Leung et al. 2017). No functional 
outcome or results, particularly for younger patients, were 
reported. Alizadehkhaiyat et al. (2013) compared RHA with 
posterior and superior extended articular surface with conven-
tional RHA for different diagnoses including 9 patients with 
CTA of whom 8 received RHA with posterior and superior 
extended articular surface. 5 of these 8 patients were revised. 
The CTA group had a mean OSS of 26 postoperatively at 4 
years’ follow up. The authors concluded that cuff deficiency 
was a major reason for failure and revision (Alizadehkhaiyat 
et al. 2013). Our results of conventional RHA and RHA with 
posterior and superior extended articular surface show poor 
patient- reported outcome for both types. 
In a single-center retrospective study Ernstbrunner et al. 
(2017) looked at RSA for irreparable rotator cuff tears in 23 
cases younger than 60 years. The functional and radiographic 
results at 10 years were good, but 6 patients were reoperated, 
mainly because of instability. The high revision rate sug-
gests that RSA might not be the best choice for all younger 
patients. In the absence of alternative treatments a selected 
group of younger patients with irreparable rotator cuff tears 
can obtain good results with RSA (Ernstbrunner et al. 2017). 
To our knowledge there are no studies reporting the results of 
revision arthroplasty after failed RHA in young patients with 
CTA, but data from the DSR showed poor outcome of the revi-
sion arthroplasty when the RHA was used for osteoarthritis 
(Rasmussen et al. 2016). Consequently the use of shoulder 
arthroplasty for younger patients should be considered care-
fully. 
The strength of our study is the systematic nationwide col-
lection of data through the DSR with high external validity. 
There is no data selection, and our results reflect the actual 
outcome in the Danish population. The study has the limi-
tations of observational studies including the possibility of 
differences in baseline characteristics such as in comorbidi-
ties and preoperative functional status. Another limitation of 
our study and other studies reporting the results of shoulder 
arthroplasty for CTA is the lack of a common definition and 
classification of CTA. There is a possible bias in distribution 
of surgeries among the participating centers and surgeons. We 
do not know whether indications for surgery or revisions are 
the same as in the studies used for comparison. Finally, we 
have no preoperative WOOS. 
To conclude, RSA had a clinically and statistically signifi-
cant better patient-reported outcome compared with RHA. 
However, for patients younger than 65 years the functional 
outcome was disappointing for both arthroplasty types. The 
optimal treatment of CTA in young patients remains a chal-
lenge. 
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